NCT05126147View on ClinicalTrials.gov

Hydroxychloroquine in Mild Graves' Orbitopathy

PHASE4RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions
Graves Ophthalmopathy
Interventions
DRUG

Hydroxychloroquine

Compare the effects of hydroxychloroquine 200mg twice daily for 6 months with those without treatment.

Trial Locations (2)

Unknown

RECRUITING

National Taiwan University Hospital, Hsin-Chu branch, Hsinchu

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER